Oscar Health, Inc. 8-K Summary
Business Context and Reporting Period
Oscar Health, Inc. (OSCR) filed this Current Report on Form 8-K on February 7, 2024, to announce its financial results for the fourth quarter and full year ended December 31, 2023. The company is incorporated in Delaware and its Class A Common Stock trades on the New York Stock Exchange.
Key Financial Metrics
This filing serves as a notification of the earnings announcement and incorporates the press release as Exhibit 99.1. The text of this 8-K form does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release (Exhibit 99.1) for detailed financial data.
Material Changes
The filing does not provide specific comparative data or material changes versus prior periods within the body of the 8-K. Such analysis is contained within the referenced press release.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, risk factors, and contingencies are detailed in the press release attached as Exhibit 99.1. This 8-K form explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2023 financial figures.
- Verify the company's liquidity position and debt levels in the full earnings release.
- Confirm any updated guidance or outlook provided by management in the press release.
- Note the legal disclaimer that the 8-K text itself does not constitute a filed financial statement under Section 18 of the Exchange Act.